Vascular Risk Factors and Findings on Brain MRI of Elderly Adult American Indians: The Strong Heart Study.
Authors:
Journal: Neuroepidemiology
Publication Type: Journal Article
Date: 2019
DOI: NIHMS1063043
ID: 30677776
Abstract
Clinical stroke is prevalent in American Indians, but the risk factors for cerebrovascular pathology have not been well-studied in this population. The purpose of this study was to correlate abnormalities on brain magnetic resonance imaging (MRI) with clinical risk factors in a cohort of elderly American Indians.
Chemical List
- Cholesterol, LDL
Reference List
- Wang W, Zhang Y, Lee ET, Howard BV, Devereux RB, Cole SA, Best LG, Welty TK, Rhoades E, Yeh J, Ali T, Kizer JR, Kamel H, Shara N, Wiebers DO, Stoner JA: Risk factors and prediction of stroke in a population with high prevalence of diabetes: the strong heart study. World J Cardiovasc Dis 2017;7 :145–162.|||Centers for Disease Control and Prevention (CDC): Racial/ethnic and socioeconomic disparities in multiple risk factors for heart disease and stroke–United States, 2003. MMWR Morb Mortal Wkly Rep 2005;54: 113–117.|||Harris R, Nelson LA, Muller C, Buchwald D: Stroke in American Indians and Alaska natives: a systematic review. Am J Public Health 2015;105: e16–e26.|||Friedman JI, Tang CY, de Haas HJ, Changchien L, Goliasch G, Dabas P, Wang V, Fayad ZA, Fuster V, Narula J: Brain imaging changes associated with risk factors for cardiovascular and cerebrovascular disease in asymptomatic patients. JACC Cardiovasc Imaging 2014;7 :1039–1053.|||Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR, Mosley TH Jr: Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 2011;76 :1879–1885.|||Longstreth WT Jr: Brain abnormalities in the elderly: frequency and predictors in the United States (the cardiovascular health study). Cardiovascular health study collaborative research group. J Neural Transm Suppl 1998;53: 9–16.|||Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM: Prevalence and risk factors of silent brain infarcts in the population- based Rotterdam Scan Study. Stroke 2002;33: 21–25.|||Marcus J, Gardener H, Rundek T, Elkind MS, Sacco RL, Decarli C, Wright CB: Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the northern Manhattan study. Stroke 2011;42 :2639–2641.|||Shibata D, Tillin T, Beauchamp N, Heasman J, Hughes AD, Park C, Gedroyc W, Chaturvedi N: African Caribbeans have greater subclinical cerebrovascular disease than Europeans: this is associated with both their elevated resting and ambulatory blood pressure and their hyperglycaemia. J Hypertens 2013;31: 2391–2399.|||Lee ET, Howard BV, Go O, Savage PJ, Fabsitz RR, Robbins DC, Welty TK: Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American diabetes association diagnostic criteria and the 1985 world health organization diagnostic criteria: the strong heart study. Diabetes Care 2000;23: 181–186.|||Howard BV: Blood pressure in 13 American Indian communities: the strong heart study. Public Health Rep 1996;111(suppl 2):47–48.|||Sambo BH; Strong Heart Study Investigators: The strong heart study: interaction with and benefit to American Indian communities. Am J Med Sci 2001;322 :282–285.|||Suchy-Dicey AM, Shibata D, Best LG, Verney SP, Longstreth WT Jr, Lee ET, Okin PM, Devereux R, O’Leary M, Ali T, Jensen PN, Muller C, Nelson LA, Rhoades E, Madhyastha T, Grabowski TJ, Beauchamp N, Umans JG, Buchwald D: Cranial magnetic resonance imaging in elderly American Indians: design, methods, and implementation of the cerebrovascular disease and its consequences in American Indians Study. Neuroepidemiology 2016;47 :67–75.|||Manolio TA, Kronmal RA, Burke GL, Poirier V, O’Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN: Magnetic resonance abnormalities and cardiovascular disease in older adults. The cardiovascular health study. Stroke 1994;25 :318–327.|||Bryan RN, Cai J, Burke G, Hutchinson RG, Liao D, Toole JF, Dagher AP, Cooper L: Prevalence and anatomic characteristics of infarct-like lesions on MR images of middle-aged adults: the atherosclerosis risk in communities study. AJNR Am J Neuroradiol 1999;20 :1273–1280.|||The atherosclerosis risk in communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129:687–702.|||Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, et al.: The cardiovascular health study: design and rationale. Ann Epidemiol 1991;1 :263–276.|||Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G: The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997;16: 149–162.|||Gibson E, Gao F, Black SE, Lobaugh NJ: Automatic segmentation of white matter hyperintensities in the elderly using FLAIR images at 3T. J Magn Reson Imaging 2010;31:1311–1322.|||Dale AM, Fischl B, Sereno MI: Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 1999;9: 179–194.|||Fischl B, Sereno MI, Dale AM: Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage 1999;9: 195–207.|||Zhang Y, Brady M, Smith S: Segmentation of brain MR images through a hidden Markov random field model and the expectationmaximization algorithm. IEEE Trans Med Imaging 2001;20: 45–57.|||Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP, Devereux RB, Kizer JR, Howard BV, Cowan LD, Yeh J, Howard WJ, Wang W, Best L, Lee ET: Incidence and risk factors for stroke in American Indians: the strong heart study. Circulation 2008;118: 1577–1584.|||Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003;3: 21.|||Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57: 289–300.|||Glickman ME, Rao SR, Schultz MR: False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 2014;67: 850–857.|||Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR: Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular health study. Arch Neurol 1998;55: 1217–1225.|||Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, Krestin GP, Breteler MM: Prevalence and risk factors of cerebral microbleeds: the Rotterdam scan study. Neurology 2008;70: 1208–1214.|||Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F: MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology 1999;52 :991–994.|||Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O’Brien JT: Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology 2004;63: 1892–1897.|||Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Tyroler HA: Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC study. Atherosclerosis risk in communities study. Stroke 1996;27: 2262–2270.|||Graff-Radford NR, Knopman DS, Penman AD, Coker LH, Mosley TH: Do systolic BP and pulse pressure relate to ventricular enlargement? Eur J Neurol 2013;20: 720–724.|||Franceschini N, Almasy L, MacCluer JW, Göring HH, Cole SA, Diego VP, Laston S, Howard BV, Lee ET, Best LG, Fabsitz RR, North KE: Diabetes-specific genetic effects on obesity traits in American Indian populations: the strong heart family study. BMC Med Genet 2008;9: 90.|||Lee ET, Howard BV, Savage PJ, Cowan LD, Fabsitz RR, Oopik AJ, Yeh J, Go O, RobbinsDC, Welty TK: Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years. The strong heart study. Diabetes Care 1995;18: 599–610.|||Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, Jack CR Jr, Graff-Radford J, Schneider AL, Windham BG, Coker LH, Albert MS, Mosley TH Jr; ARIC Neurocognitive Investigators: Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neuro- cognitive study. Stroke 2015;46: 433–440.|||Knopman DS, Mosley TH, Catellier DJ, Sharrett AR; Atherosclerosis Risk in Communities (ARIC) Study: Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 2005;65: 876–881.|||de Bresser J, Tiehuis AM, van den Berg E, Reijmer YD, Jongen C, Kappelle LJ, Mali WP, Viergever MA, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group: Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 2010;33: 1309–1314.|||Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C: Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77: 461–468.|||Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman AP, Kappelle LJ, Mali WP; SMART Study Group: Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 2008;39: 1600–1603.|||Toth C: Diabetes and neurodegeneration in the brain. Handb Clin Neurol 2014;126: 489–511.|||Whitlow CT, Sink KM, Divers J, Smith SC, Xu J, Palmer ND, Hugenschmidt CE, Williamson JD, Bowden DW, Freedman BI, Maldjian JA: Effects of type 2 diabetes on brain structure and cognitive function: African American- diabetes heart study MIND. AJNR Am J Neuroradiol 2015;36: 1648–1653.|||Mayeda ER, Haan MN, Neuhaus J, Yaffe K, Knopman DS, Sharrett AR, Griswold ME, Mosley TH: Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: the ARIC Brain MRI Study. Neuroepidemiology 2014;43: 220–227.|||Korf ES, White LR, Scheltens P, Launer LJ: Brain aging in very old men with type 2 diabetes: the Honolulu-Asia aging study. Diabetes Care 2006;29: 2268–2274.|||Araki Y, Nomura M, Tanaka H, Yamamoto H, Yamamoto T, Tsukaguchi I, Nakamura H: MRI of the brain in diabetes mellitus. Neuroradiology 1994;36: 101–103.|||Moran C, Tapp RJ, Hughes AD, Magnussen CG, Blizzard L, Phan TG, Beare R, Witt N, Venn A, Münch G, Amaratunge BC, Srikanth V: The association of type 2 diabetes mellitus with cerebral gray matter volume is independent of retinal vascular architecture and retinopathy. J Diabetes Res 2016;2016: 6328953.|||Verdile G, Fuller SJ, Martins RN: The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 2015;84: 22–38.|||Welty TK, Lee ET, Yeh J, Cowan LD, Go O, Fabsitz RR, Le NA, Oopik AJ, Robbins DC, Howard BV: Cardiovascular disease risk factors among American Indians. The strong heart study. Am J Epidemiol 1995;142: 269–287.|||Rhoades DA, Welty TK, Wang W, Yeh F, Devereux RB, Fabsitz RR, Lee ET, Howard BV: Aging and the prevalence of cardiovascular disease risk factors in older American Indians: the strong heart study. J Am Geriatr Soc 2007;55: 87–94.|||Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, Massasa E, Cloonan L, Gilson A, Capozzo K, Cortellini L, Ois A, Cuadrado-Godia E, Rodriguez-Campello A, Furie KL, Roquer J, Rosand J, Rost NS: Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke 2010;41: 437–442.|||Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, Manolio TA, Lefkowitz D, Jungreis C, Hirsch CH, O’Leary DH, Furberg CD: Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the cardiovascular health study. Stroke 2005;36: 56–61.|||Ichikawa H, Mukai M, Ohno H, Shimizu Y, Itaya K, Kawamura M: Deep white matter hyperintensities, decreased serum low-density lipoprotein, and dilative large arteriopathy. J Stroke Cerebrovasc Dis 2012;21: 225–230.|||Dietschy JM, Turley SD: Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004;45: 1375–1397.|||Goritz C, Mauch DH, Pfrieger FW: Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol Cell Neurosci 2005;29: 190–201.|||Boon A, Lodder J, Heuts-van Raak L, Kessels F: Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 1994;25: 2384–2390.|||Vermeer SE, Longstreth WT Jr, Koudstaal PJ: Silent brain infarcts: a systematic review. Lancet Neurol 2007;6: 611–619.